Prolonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcome
- PMID: 25009562
- PMCID: PMC4076452
- DOI: 10.3969/j.issn.1671-5411.2014.02.012
Prolonged high-pressure balloon angioplasty of femoropopliteal lesions: Impact on stent implantation rate and mid-term outcome
Abstract
Objectives: To assess the impact on stent implantation rate and mid-term outcomes of prolonged high pressure angioplasty of femoropopliteal lesions.
Methods: We retrospectively enrolled 620 consecutive patients from January 2011 to December 2011 (75.6 ± 12.3 years, 355 males, 76.5% in Rutherford class 5-6), referred for critical limb ischemia and submitted to prolonged high-pressure angioplasty of femoropopliteal lesions. The definition of prolonged high-pressure angioplasty includes dilation to at least 18 atm for at least 120 s. Procedural data, and clinical and instrumental follow-up were analyzed to assess stent implantation rate and mid-term outcomes.
Results: The preferred approach was ipsilateral femoral antegrade in 433/620 patients (69.7%) and contralateral cross-over in 164/620 (26.4%) and popliteal retrograde + femoral antegrade in 23/620 (3.7%). Techniques included subintimal angioplasty in 427/620 patients (68.8%) and endoluminal angioplasty in 193/620 patients (31.2%). The prolonged high pressure balloon angioplasty procedure was successful in 86.2% (minor intra-procedural complications rate 15.7 %), stent implantation was performed in 74 patients (11.9%), with a significant improvement of ankle-brachial index (0.29 ± 0.6 vs. 0.88 ± 0.3, P < 00.1) and Rutherford class (5.3 ± 0.8 vs. 0.7 ± 1.9, P < 0.01), a primary patency rate of 86.7%, restenosis of 18.6 % on Doppler ultrasound and a target lesion revascularization of 14.8% at a mean follow-up of 18.1 ± 6.4 months (range 1-24 months). Secondary patency rate was 87.7%.
Conclusions: Prolonged high pressure angioplasty of femoropopliteal lesions appears to be safe and effective allowing for an acceptable patency and restenosis rates on mid-term.
Keywords: Angioplasty; Balloon; Peripheral artery disease; Stent.
Figures


Similar articles
-
PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.J Endovasc Ther. 2014 Jun;21(3):373-80. doi: 10.1583/13-4637R.1. J Endovasc Ther. 2014. PMID: 24915584
-
[Outcome of endovascular therapy of iliac, superficial femoral and popliteal arteries in 136 patients].Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Nov;35(11):1015-9. Zhonghua Xin Xue Guan Bing Za Zhi. 2007. PMID: 18269822 Chinese.
-
Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial.Circulation. 2013 Jun 25;127(25):2535-41. doi: 10.1161/CIRCULATIONAHA.113.001849. Epub 2013 May 21. Circulation. 2013. PMID: 23694965 Clinical Trial.
-
Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.J Vasc Surg. 2019 Sep;70(3):981-995.e10. doi: 10.1016/j.jvs.2019.01.080. Epub 2019 May 21. J Vasc Surg. 2019. PMID: 31126769
-
Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.J Vasc Interv Radiol. 2016 Aug;27(8):1195-203. doi: 10.1016/j.jvir.2016.05.003. Epub 2016 Jun 24. J Vasc Interv Radiol. 2016. PMID: 27350033 Review.
Cited by
-
Perspectives on Using Platelet-Rich Plasma and Platelet-Rich Fibrin for Managing Patients with Critical Lower Limb Ischemia After Partial Foot Amputation.J Med Life. 2020 Jan-Mar;13(1):45-49. doi: 10.25122/jml-2020-0028. J Med Life. 2020. PMID: 32341700 Free PMC article. Clinical Trial.
-
Telmisartan Loaded Nanofibers Enhance Re-Endothelialization and Inhibit Neointimal Hyperplasia.Pharmaceutics. 2021 Oct 21;13(11):1756. doi: 10.3390/pharmaceutics13111756. Pharmaceutics. 2021. PMID: 34834171 Free PMC article.
-
Impact of number of run-off vessels on interwoven nitinol mesh stents patency in the femoropopliteal segment.J Geriatr Cardiol. 2020 Sep 28;17(9):561-565. doi: 10.11909/j.issn.1671-5411.2020.09.002. J Geriatr Cardiol. 2020. PMID: 33117420 Free PMC article.
-
Do Balloon Catheters have a Different Radial Force Along Their Longitudinal Axis?Cardiovasc Intervent Radiol. 2024 Sep;47(9):1278-1285. doi: 10.1007/s00270-024-03716-x. Epub 2024 Apr 19. Cardiovasc Intervent Radiol. 2024. PMID: 38639779 Free PMC article.
References
-
- BASIL trial investigators Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934. - PubMed
-
- Acin F, de Haro J, Bleda S, et al. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther. 2012;19:585–595. - PubMed
-
- Davaine JM, Quérat J, Guyomarch B, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year. Eur J Vasc Endovasc Surg. 2013;46:201–212. - PubMed
-
- Liistro F, Grotti S, Porto I, et al. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (Drug Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery) JACC Cardiovasc Interv. 2013;6:1295–1302. - PubMed
-
- Fusaro M, Cassese S, Ndrepepa G, et al. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison. Int J Cardiol. 2013;168:4002–4009. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous